Aesther Healthcare Acquisition Corp. Contracts & Agreements
163 Contracts & Agreements
- Business Finance (68 contracts)
- Business Operations (3)
- Human Resources (14)
- Intellectual Property (38)
- Mergers & Acquisitions (5)
- Uncategorized (35)
- Seventh Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Filed With SEC on December 23, 2024)
- Side Letter Agreement, dated October 2, 2023, by and between Ocean Biomedical, Inc. and Polar Multi-Strategy Master Fund (Filed With SEC on December 23, 2024)
- Seventh Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Filed With SEC on December 23, 2024)
- Side Letter Agreement, dated October 2, 2023, by and between Ocean Biomedical, Inc. and Polar Multi-Strategy Master Fund (Filed With SEC on December 23, 2024)
- Exchange Agreement with Institutional Investor (Filed With SEC on July 23, 2024)
- Seventh Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Filed With SEC on April 15, 2024)
- Side Letter Agreement, dated October 2, 2023, by and between Ocean Biomedical, Inc. and Polar Multi-Strategy Master Fund (Filed With SEC on April 15, 2024)
- Amended and Restated Contribution Agreement, dated October 11, 2023, between Ocean Biomedical, Inc., Virion Therapeutics, LLC and Poseidon Bio LLC (Filed With SEC on October 12, 2023)
- Second Amended and Restated Limited Liability Company Operating Agreement of Virion Therapeutics, LLC, dated October 11, 2023 (Filed With SEC on October 12, 2023)
- First Amendment to Common Stock Purchase Agreement, dated October 4, 2023, between Ocean Biomedical, Inc. and White Lion Capital LLC (Filed With SEC on October 6, 2023)
- Side Letter, dated October 2, 2023, between Ocean Biomedical, Inc. and Polar Multi-Strategy Master Fund (Filed With SEC on October 3, 2023)
- Amendment to Loan Agreement, dated June 2, 2023, between the Company and McKra Investments III (Filed With SEC on June 8, 2023)
- Omnibus Amendment to Loan Agreements, dated June 2, 2023, between the Company and Second Street Capital, LLC (Filed With SEC on June 8, 2023)
- Guaranty, dated May 25, 2023, between Ocean Biomedical Holdings, Inc., Ocean ChitoRx Inc, Ocean ChitofibroRx Inc., Ocean Sihoma Inc., Ocean Promise, Inc., and Alto Opportunity... (Filed With SEC on June 1, 2023)
- Security and Pledge Agreement, dated May 25, 2023, between the Company, Ocean Biomedical Holdings, Inc., Ocean ChitoRx Inc, Ocean ChitofibroRx Inc., Ocean Sihoma Inc., Ocean... (Filed With SEC on June 1, 2023)
- Registration Rights Agreement, dated May 25, 2023, between the Company and Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B (Filed With SEC on June 1, 2023)
- Amendment No. 1 to Securities Purchase Agreement between the Company and the Investor dated May 25, 2023 (Filed With SEC on May 26, 2023)
- Warrant No. 2023-7 to Subscribe to Common Shares issued by the Registrant to Special Forces F9, LLC (Filed With SEC on May 24, 2023)
- Form of Senior Secured Convertible Note (Filed With SEC on May 16, 2023)
- Form of Warrant (Filed With SEC on May 16, 2023)
- Security and Pledge Agreement (Filed With SEC on May 16, 2023)
- Security and Pledge Agreement (Filed With SEC on May 16, 2023)
- Securities Purchase Agreement (Filed With SEC on May 16, 2023)
- Registration Rights Agreement (Filed With SEC on May 16, 2023)
- Fifth Amendment to Loan Agreement between the Registrant and Second Street Capital, LLC effective as of March 31, 2023 (Filed With SEC on April 21, 2023)
- Fifth Amendment to Loan Agreement between the Registrant and Second Street Capital, LLC effective as of March 31, 2023 (Filed With SEC on April 21, 2023)
- Warrant No. 2023-3 to Subscribe to Common Shares issued by the Registrant to McKra Investments III (Filed With SEC on April 21, 2023)
- Warrant No. 2023-4 to Subscribe to Common Shares issued by the Registrant to Second Street Capital, LLC (Filed With SEC on April 21, 2023)
- Warrant No. 2023-5 to Subscribe to Common Shares issued by the Registrant to Second Street Capital, LLC (Filed With SEC on April 21, 2023)
- Warrant No. 2023-6 to Subscribe to Common Shares issued by the Registrant to Second Street Capital, LLC (Filed With SEC on April 21, 2023)
- Consent Agreement, dated April 18, 2023, by and among Ocean Biomedical, Inc. (f/k/a Aesther Healthcare Acquisition Corp.) and White Lion Capital LLC (Filed With SEC on April 21, 2023)
- Fourth Amendment to Loan Agreement between the Registrant and Second Street Capital, LLC effective as of February 15, 2023 (Filed With SEC on March 31, 2023)
- Fourth Amendment to Loan Agreement between the Registrant and Second Street Capital, LLC effective as of February 15, 2023 (Filed With SEC on March 31, 2023)
- Warrant No. 2023-1 to Subscribe to Common Shares issued by the Registrant to Second Street Capital, LLC (Filed With SEC on March 31, 2023)
- Warrant No. 2023-2 to Subscribe to Common Shares issued by the Registrant to Second Street Capital, LLC (Filed With SEC on March 31, 2023)
- Assignment and Novation Agreement, dated February 13, 2023, by and between Aesther Healthcare Acquisition Corp. (n/k/a Ocean Biomedical, Inc.), Ocean Biomedical, Inc. (n/k/a Ocean... (Filed With SEC on March 31, 2023)
- Assignment and Novation Agreement, dated February 13, 2023, by and between Aesther Healthcare Acquisition Corp. (n/k/a Ocean Biomedical, Inc.), Ocean Biomedical, Inc. (n/k/a Ocean... (Filed With SEC on March 31, 2023)
- Subscription Agreement, dated February 14, 2023, by and between Aesther Healthcare Acquisition Corp. (n/k/a Ocean Biomedical, Inc.), Ocean Biomedical, Inc. (n/k/a Ocean Biomedical... (Filed With SEC on March 31, 2023)
- Promissory Note, dated February 14, 2023, issued to EF Hutton, division of Benchmark Investments, LLC by Aesther Healthcare Acquisition Corp. (n/k/a Ocean Biomedical, Inc.) (Filed With SEC on March 31, 2023)
- Loan and Transfer Agreement, by and among Aesther Healthcare Acquisition Corp. (n/k/a Ocean Biomedical, Inc.), Aesther Healthcare Sponsor, LLC and NPIC Limited dated December 13,... (Filed With SEC on March 31, 2023)
- Loan Agreement, dated March 28, 2023, by and among Ocean Biomedical, Inc. (f/k/a Aesther Healthcare Acquisition Corp.) and McKra Investments III (Filed With SEC on March 31, 2023)
- Loan Agreement, dated March 29, 2023, by and among Ocean Biomedical, Inc. (f/k/a Aesther Healthcare Acquisition Corp.) and Second Street Capital, LLC (Filed With SEC on March 31, 2023)
- Loan and Transfer Agreement, by and among Aesther Healthcare Acquisition Corp., Aesther Healthcare Sponsor, LLC, and NPIC Limited dated December 13, 2022, as modified by that... (Filed With SEC on March 27, 2023)
- Assignment and Novation Agreement by and between Vellar Opportunity Fund SPV LLC Series 3, Meteora Special Opportunity Fund I, LP, Meteora Capital Partners, LP and Meteora Select... (Filed With SEC on February 17, 2023)
- Assignment and Novation Agreement by and between Vellar Opportunity Fund SPV LLC Series 3, Polar Multi-Strategy Master Fund, Aesther Healthcare Acquisition Corp. and Ocean... (Filed With SEC on February 17, 2023)
- Subscription Agreement by and between Aesther Healthcare Acquisition Corp., Ocean Biomedical, Inc. and Polar Multi-Strategy Master Fund dated as of February 14, 2023 (Filed With SEC on February 17, 2023)
- Fifth Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Filed With SEC on February 15, 2023)
- Sixth Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Filed With SEC on February 15, 2023)
- Exclusive License Agreement BROWN ID 2613 Bispecific (FRG)xAnti-PD-1 (FRGxPD-1) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated July... (Filed With SEC on February 15, 2023)
- First Amendment to Exclusive License Agreement (BROWN ID 2613) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated March 21, 2021 (Filed With SEC on February 15, 2023)
- Second Amendment to Exclusive License Agreement (BROWN ID 2613) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated August 31, 2021 (Filed With SEC on February 15, 2023)
- Third Amendment to Exclusive License Agreement (BROWN ID 2613) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated March 25, 2022 (Filed With SEC on February 15, 2023)
- Fourth Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Filed With SEC on February 15, 2023)
- Fifth Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Filed With SEC on February 15, 2023)
- Sixth Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Filed With SEC on February 15, 2023)
- Exclusive License Agreement BROWN ID 2502 (Chit1) Small Molecule Antifibrotic between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated July... (Filed With SEC on February 15, 2023)
- First Amendment to Exclusive License Agreement (BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated March 21, 2021 (Filed With SEC on February 15, 2023)
- Second Amendment to Exclusive License Agreement (BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated August 31, 2021 (Filed With SEC on February 15, 2023)
- Third Amendment to Exclusive License Agreement (BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated March 25, 2022 (Filed With SEC on February 15, 2023)
- Fourth Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Filed With SEC on February 15, 2023)
- Fifth Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Filed With SEC on February 15, 2023)
- Sixth Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Filed With SEC on February 15, 2023)
- Exclusive License Agreement Brown ID 3085J Compositions and Treatments for Malaria, dated September 13, 2022, between Elkurt, Inc. and Ocean Biomedical, Inc. (n/k/a Ocean... (Filed With SEC on February 15, 2023)
- Exclusive License Agreement RIH #154 PfsLSP-1 a Vaccine for Falciparum Malaria RIH #305 Antibodies to Pfgarp Kill Plasmodium Falciparum Malaria Parasites and Protect Against... (Filed With SEC on February 15, 2023)
- First Amendment to Exclusive License Agreement RIH #154 PfsLSP-1 a Vaccine for Falciparum Malaria RIH #305 Antibodies to Pfgarp Kill Plasmodium Falciparum Malaria Parasites and... (Filed With SEC on February 15, 2023)
- Second Amendment to Exclusive License Agreement RIH #154 PfsLSP-1 a Vaccine for Falciparum Malaria RIH #305 Antibodies to Pfgarp Kill Plasmodium Falciparum Malaria Parasites and... (Filed With SEC on February 15, 2023)
- Third Amendment to Exclusive License Agreement (RIH #154) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated March 25, 2022 (Filed With SEC on February 15, 2023)
- Fourth Amendment to Exclusive License Agreement RIH #154 PfsLSP-1 a Vaccine for Falciparum Malaria RIH #305 Antibodies to Pfgarp Kill Plasmodium Falciparum Malaria Parasites and... (Filed With SEC on February 15, 2023)
- Fifth Amendment to Exclusive License Agreement (RIH #154) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated August 26, 2022 (Filed With SEC on February 15, 2023)
- Loan Agreement between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Second Street Capital, LLC dated February 22, 2022 (Filed With SEC on February 15, 2023)
- First Amendment to Loan Agreement between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Second Street Capital, LLC dated April 22, 2022 (Filed With SEC on February 15, 2023)
- Second Amendment to Loan Agreement between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Second Street Capital, LLC dated September 30, 2022 (Filed With SEC on February 15, 2023)
- Third Amendment to Loan Agreement between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Second Street Capital, LLC dated December 30, 2022 (Filed With SEC on February 15, 2023)
- Loan Agreement between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Second Street Capital, LLC dated April 22, 2022 (Filed With SEC on February 15, 2023)
- First Amendment to Loan Agreement between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Second Street Capital, LLC dated September 30, 2022 (Filed With SEC on February 15, 2023)
- Second Amendment to Loan Agreement between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Second Street Capital, LLC dated December 30, 2022 (Filed With SEC on February 15, 2023)
- Third Amendment to Loan Agreement between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Second Street Capital, LLC dated January 10, 2023 (Filed With SEC on February 15, 2023)
- Warrant Exchange Agreement between Second Street Capital, LLC, Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Aesther Healthcare Acquisition Corp. (n/k/a Ocean... (Filed With SEC on February 15, 2023)
- Warrant No. 2022-1 to Subscribe to Common Shares issued by the Registrant to Second Street Capital, LLC (Filed With SEC on February 15, 2023)
- Warrant No. 2022-2 to Subscribe to Common Shares issued by the Registrant to Second Street Capital, LLC (Filed With SEC on February 15, 2023)
- Warrant No. 3 to Subscribe to Common Shares issued by the Registrant to Second Street Capital, LLC (Filed With SEC on February 15, 2023)
- Development and Manufacturing Services Agreement between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.), Lonza Sales AG and Lonza AG dated December 15, 2020 (Filed With SEC on February 15, 2023)
- Amendment to Agreement and Plan of Merger, dated as of December 5, 2022, by and between Aesther Healthcare Acquisition Corp. (n/k/a Ocean Biomedical, Inc.), AHAC Merger Sub Inc.,... (Filed With SEC on February 15, 2023)
- Lock-Up Agreement, dated as of February 14, 2023, by and between the Registrant and Dr. Chirinjeev Kathuria (Filed With SEC on February 15, 2023)
- Lock-Up Agreement, dated as of February 14, 2023, by and between the Registrant and Poseidon Bio, LLC (Filed With SEC on February 15, 2023)
- Non-Competition and Non-Solicitation Agreement, dated as of February 14, 2023, by and between the Registrant and Dr. Chirinjeev Kathuria (Filed With SEC on February 15, 2023)
- 2022 Stock Option and Incentive Plan and Form of Non-Qualified Stock Option Agreement for Non-Employee Directors (Filed With SEC on February 15, 2023)
- 2022 Employee Stock Purchase Plan (Filed With SEC on February 15, 2023)
- Offer Letter between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Elizabeth Ng, dated February 22, 2021 (Filed With SEC on February 15, 2023)
- Amendment to February 22, 2021 Offer of Employment between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Elizabeth Ng dated August 2, 2021 (Filed With SEC on February 15, 2023)
- Offer Letter between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Chirinjeev Kathuria, dated February 22, 2021 (Filed With SEC on February 15, 2023)
- Amendment to February 22, 2021 Offer of Employment between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Chirinjeev Kathuria dated August 2, 2021 (Filed With SEC on February 15, 2023)
- Offer Letter between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Daniel Behr, dated February 22, 2021 (Filed With SEC on February 15, 2023)
- Amendment to February 22, 2021 Offer of Employment between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Daniel Behr dated August 2, 2021 (Filed With SEC on February 15, 2023)
- Offer Letter between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Gurinder Kalra, dated February 22, 2021 (Filed With SEC on February 15, 2023)
- Amendment to February 22, 2021 Offer Letter between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Gurinder Kalra dated August 2, 2021 (Filed With SEC on February 15, 2023)
- Second Amendment to February 22, 2021 Offer of Employment between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Gurinder Kalra dated April 22, 2022 (Filed With SEC on February 15, 2023)
- Offer Letter between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Inderjote Kathuria, dated February 22, 2021 (Filed With SEC on February 15, 2023)
- Amendment to February 22, 2021 Offer of Employment between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Inderjote Kathuria dated August 2, 2021 (Filed With SEC on February 15, 2023)
- Offer of Employment between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Robert Sweeney dated June 14, 2021 (Filed With SEC on February 15, 2023)
- Amendment to June 14, 2021 Offer of Employment between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Robert Sweeney dated August 2, 2021 (Filed With SEC on February 15, 2023)
- Second Amendment to June 14, 2021 Offer of Employment between Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) and Robert Sweeney dated April 22, 2022 (Filed With SEC on February 15, 2023)
- Consulting Agreement between Jonathan Kurtis and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.), dated February 22, 2021 (Filed With SEC on February 15, 2023)
- Amendment to Consulting Agreement between Jonathan Kurtis and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated August 2, 2021 (Filed With SEC on February 15, 2023)
- Amendment No. 2 to Consulting Agreement between Jonathan Kurtis and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) effective as of December 31, 2021 (Filed With SEC on February 15, 2023)
- Form of Director and Officer Indemnification Agreement, by and between the Registrant and each of its directors, the Chief Executive Officer and the Chief Financial Officer (Filed With SEC on February 15, 2023)
- Exclusive License Agreement BROWN ID 2465, 2576, 2587 (FRG) Antibody between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated July 31, 2020 (Filed With SEC on February 15, 2023)
- First Amendment to Exclusive License Agreement (BROWN ID 2465, 2576, 2587) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated March 21,... (Filed With SEC on February 15, 2023)
- Second Amendment to Exclusive License Agreement (BROWN ID 2465, 2576, 2587) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated August 31,... (Filed With SEC on February 15, 2023)
- Third Amendment to Exclusive License Agreement (BROWN ID 2465, 2576, 2587) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated March 25,... (Filed With SEC on February 15, 2023)
- Fourth Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Filed With SEC on February 15, 2023)
- Fifth Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Filed With SEC on February 15, 2023)
- Sixth Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Filed With SEC on February 15, 2023)
- Exclusive License Agreement BROWN ID 3039 Bi Specific Antibody Anti-CTLA4 between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated July 31,... (Filed With SEC on February 15, 2023)
- First Amendment to Exclusive License Agreement (BROWN ID 3039) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated March 21, 2021 (Filed With SEC on February 15, 2023)
- Second Amendment to Exclusive License Agreement (BROWN ID 3039) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated August 31, 2021 (Filed With SEC on February 15, 2023)
- Third Amendment to Exclusive License Agreement (BROWN ID 3039) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated March 25, 2022 (Filed With SEC on February 15, 2023)
- Fourth Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Filed With SEC on February 15, 2023)
- Amended and Restated OTC Equity Prepaid Forward Transaction (Backstop Agreement), dated February 12, 2023 (Filed With SEC on February 13, 2023)
- Amended and Restated OTC Equity Prepaid Forward Transaction (Backstop Agreement), dated February 10, 2023 (Filed With SEC on February 10, 2023)
- Amendment to Agreement and Plan of Merger, dated as of December 5, 2022, by and between Aesther, Merger Sub, Sponsor, Ocean Biomedical, and Dr. Chirinjeev Kathuria (Filed With SEC on December 8, 2022)
- Amendment to Forward Share Purchase Agreement, dated as of November 17, 2022, by and between the Company, Ocean Biomedical, and the Investors (Filed With SEC on November 21, 2022)
- First Amendment to Insider Letter effective September 2, 2022, between Aesther Healthcare Acquisition Corp., Aesther Healthcare Sponsor, LLC, EF Hutton, division of Benchmark... (Filed With SEC on October 17, 2022)
- Form of Loan and Transfer Agreement dated September 15, 2022, between the lenders party thereto, Aesther Healthcare Sponsor, LLC and Aesther Healthcare Acquisition Corp (Filed With SEC on October 17, 2022)
- Forward Share Purchase Agreement (Meteora Backstop Agreement), dated October 4, 2022 (Filed With SEC on October 5, 2022)
- Common Stock Purchase Agreement, dated as of September 7, 2022, by and between Aesther Healthcare Acquisition Corp. and White Lion Capital LLC (Filed With SEC on September 9, 2022)
- Registration Rights Agreement, dated as of September 7, 2022, by and between Aesther Healthcare Acquisition Corp. and White Lion Capital LLC (Filed With SEC on September 9, 2022)
- Merger Agreement, dated August 31, 2022 (Filed With SEC on September 8, 2022)
- OTC Equity Prepaid Forward Transaction (Backstop Agreement), dated August 31, 2022 (Filed With SEC on September 8, 2022)
- Letter Agreement, dated as of July 18, 2022, by and among Aesther Healthcare Acquisition Corp., AHAC Merger Sub Inc., Aesther Healthcare Sponsor, LLC in the capacity as the... (Filed With SEC on July 19, 2022)
- Common Stock Purchase Agreement, dated as of July 6, 2022, by and between Aesther Healthcare Acquisition Corp. and White Lion Capital LLC (Filed With SEC on July 8, 2022)
- Registration Rights Agreement, dated as of July 6, 2022, by and between Aesther Healthcare Acquisition Corp. and White Lion Capital LLC (Filed With SEC on July 8, 2022)
- Agreement and Plan of Merger, dated as of May 26, 2022, by and among Aesther Healthcare Acquisition Corp., AHAC Merger Sub Inc., Aesther Healthcare Sponsor, LLC in the capacity as... (Filed With SEC on June 2, 2022)
- Form of Non-Competition Agreement (Filed With SEC on June 2, 2022)
- Form of Lock-Up Agreement (Filed With SEC on June 2, 2022)
- Form of Sponsor Agreement (Filed With SEC on June 2, 2022)
- Description of Registered Securities (Filed With SEC on January 31, 2022)
- Underwriting Agreement, dated September 14, 2021, by and between the Company and EF Hutton, division of Benchmark Investments, LLC (Filed With SEC on September 17, 2021)
- Warrant Agreement, dated September 14, 2021, by and between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on September 17, 2021)
- Investment Management Trust Agreement, dated September 14, 2021, by and between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on September 17, 2021)
- Registration Rights Agreement, dated September 14, 2021, by and among the Company and the Sponsor (Filed With SEC on September 17, 2021)
- Letter Agreement, dated September 14, 2021, by and among the Company, its officers and directors and the Sponsor (Filed With SEC on September 17, 2021)
- Placement Warrant Purchase Agreement, dated September 14, 2021, by and between the Company and the Sponsor (Filed With SEC on September 17, 2021)
- Administrative Support Agreement, dated September 14, 2021, by and between the Company and the Sponsor (Filed With SEC on September 17, 2021)
- Indemnity Agreement, dated September 8, 2021, by and among the Company and Suren Ajjarapu (Filed With SEC on September 17, 2021)
- Indemnity Agreement, dated September 8, 2021, by and among the Company and Howard A. Doss (Filed With SEC on September 17, 2021)
- Indemnity Agreement, dated September 14, 2021, by and among the Company and Siva Saravanan (Filed With SEC on September 17, 2021)
- Indemnity Agreement, dated September 14, 2021, by and among the Company and Michael L. Peterson (Filed With SEC on September 17, 2021)
- Indemnity Agreement, dated September 14, 2021, by and among the Company and Venkatesh Srinivasan (Filed With SEC on September 17, 2021)
- Indemnity Agreement, dated September 14, 2021, by and among the Company and Donald G. Fell (Filed With SEC on September 17, 2021)
- Form of Underwriting Agreement (Filed With SEC on September 2, 2021)
- Specimen Unit Certificate (Filed With SEC on September 2, 2021)
- Specimen Class A Common Stock Certificate (Filed With SEC on September 2, 2021)
- Specimen Warrant Certificate (included in Exhibit 4.4) (Filed With SEC on September 2, 2021)
- Form of Letter Agreement among the Registrant and our officers, directors and Aesther Healthcare Sponsor, LLC (Filed With SEC on September 2, 2021)
- Promissory Note, dated June 30, 2021, issued to Aesther Healthcare Sponsor, LLC (Filed With SEC on September 2, 2021)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company, LLC and the Registrant (Filed With SEC on September 2, 2021)
- Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on September 2, 2021)
- Securities Subscription Agreement, dated June 30, 2021, between the Registrant and Aesther Healthcare Sponsor, LLC (Filed With SEC on September 2, 2021)
- Form of Placement Warrant Purchase Agreement between the Registrant and Aesther Healthcare Sponsor, LLC (Filed With SEC on September 2, 2021)
- Form of Indemnity Agreement (Filed With SEC on September 2, 2021)
- Form of Administrative Support Agreement by and between the Registrant and Aesther Healthcare Sponsor, LLC (Filed With SEC on September 2, 2021)
- Specimen Warrant Certificate (included in Exhibit 4.4) (Filed With SEC on July 19, 2021)
